Skip to main content
Novo NordiskIndustry prediction

Out of the Lab: Operationalizing Cell and Gene Therapy discusses Novo Nordisk: industry prediction

Source

Quotes from the episode

  • “And we see now with Nova Holdings acquiring Catalan, that is a major event... it does exemplify the fact that you know, Novo Holdings and Novo Nordisk now have got in-house critical assets.”

    Hedley ReesOut of the Lab: Operationalizing Cell and Gene TherapyView

Extracted by Autobound

From the Signal API record
Signal
Industry prediction

What this signalsWhat leaders say on podcasts often shows their current priorities.

Speaker
Hedley Rees
Speaker role
Third party
Event date
Jul 2026

Latest signals at other companies

The full record

From the Signal API record

People

  • Hedley ReesSpeaker (third party)

Details

Podcast
Out of the Lab: Operationalizing Cell and Gene Therapy
Timing
Ongoing state
Recorded at estimate
2026-07

Extraction

Detected
Aug 24, 2026
signal_type
podcast-company
signal_subtype
industryPrediction

Use this data

Get every podcast signal for Novo Nordisk and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Novo Nordisk this week?”

  2. Send it to your own tools

    The Signal API returns podcast signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full podcast-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/bc074c2f-a1ed-591d-8743-bf9881b8fefb returns this record as JSON. POST /v1/companies/enrich returns every signal for novonordisk.com.

{
  "signal_id": "bc074c2f-a1ed-591d-8743-bf9881b8fefb",
  "signal_type": "podcast-company",
  "signal_subtype": "industryPrediction",
  "detected_at": "2026-08-24T10:25:19+00:00",
  "company": {
    "name": "Novo Nordisk",
    "domain": "novonordisk.com"
  },
  "data": {
    "is_ad": false,
    "quotes": [
      "And we see now with Nova Holdings acquiring Catalan, that is a major event... it does exemplify the fact that you know, Novo Holdings and Novo Nordisk now have got in-house critical assets."
    ],
    "timing": "ongoing_state",
    "speaker": "Hedley Rees",
    "evidence": "And we see now with Nova Holdings acquiring Catalan, that is a major event... it does exemplify the fact that you know, Novo Holdings and Novo Nordisk now have got in-house critical assets.",
    "headline": "Novo Nordisk · industryPrediction · ongoing_state (2026-07)",
    "episode_id": "57713428202",
    "event_date": "2026-07",
    "episode_url": "https://podcasters.spotify.com/pod/show/nico7350/episodes/The-Outsourcing-Trap-Why-Pharma-Needs-to-Reclaim-Manufacturing--Hedley-Rees-e3m37ji",
    "podcast_name": "Out of the Lab: Operationalizing Cell and Gene Therapy",
    "published_at": "2026-07-14",
    "episode_title": "The Outsourcing Trap: Why Pharma Needs to Reclaim Manufacturing | Hedley Rees",
    "date_confidence": "inferred",
    "event_date_text": "now",
    "speaker_relation": "third_party",
    "transcript_source": "transcript",
    "recorded_at_estimate": "2026-07"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.